Apotex gets FDA ultimatum; Teva recalls propofol

> Apotex got an ultimatum from the FDA: Fix your manufacturing problems, or forget introducing new meds in the U.S. Report

> Teva, maker of the anesthetic propofol, has a massive recall underway following dozens of patients getting sick from two batches. Bacterial contamination is the chief suspect. Article

> EMCOR will provide facilities and energy management services for Patheon at the contract manufacturer's three U.S. plants in Manati and Caguas, Puerto Rico, and Cincinnati. Release

> A groundbreaking ceremony took place recently for a planned 200,000-square-foot, $30-million Viva Biopharm manufacturing plant in Blaine, WA. Article

> The Pharmaceutical Council of Nigeria cites an increasing rate of fake pharmaceutical products in circulation, and attributed the trend to the failure of manufacturers to conform to standards. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.